These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20722789)

  • 1. Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy.
    Traish AM; Gooren LJ
    J Sex Med; 2010 Nov; 7(11):3758-64. PubMed ID: 20722789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Safety of Physiological Testosterone Therapy in Women: Lessons From Female-to-Male Transsexuals (FMT) Treated With Pharmacological Testosterone Therapy.
    Seftel A
    J Urol; 2011 Apr; 185(4):1399. PubMed ID: 22098980
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies.
    Braunstein GD
    J Sex Med; 2007 Jul; 4(4 Pt 1):859-66. PubMed ID: 17627735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals.
    Mueller A; Haeberle L; Zollver H; Claassen T; Kronawitter D; Oppelt PG; Cupisti S; Beckmann MW; Dittrich R
    J Sex Med; 2010 Sep; 7(9):3190-8. PubMed ID: 20584125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens and Female Sexual Function and Dysfunction--Findings From the Fourth International Consultation of Sexual Medicine.
    Davis SR; Worsley R; Miller KK; Parish SJ; Santoro N
    J Sex Med; 2016 Feb; 13(2):168-78. PubMed ID: 26953831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females.
    Gooren LJG; Giltay EJ
    J Sex Med; 2008 Apr; 5(4):765-776. PubMed ID: 17971101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg SA; Simon JA; Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone and the breast.
    Shufelt CL; Braunstein GD
    Menopause Int; 2008 Sep; 14(3):117-22. PubMed ID: 18714077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
    Permpongkosol S; Tantirangsee N; Ratana-olarn K
    J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case series of androgen use in breast cancer survivors with sexual dysfunction.
    Krychman ML; Stelling CJ; Carter J; Hudis CA
    J Sex Med; 2007 Nov; 4(6):1769-74. PubMed ID: 17666036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
    Basaria S; Dobs AS
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4743-52. PubMed ID: 16984993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR
    Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen therapy in women, beyond libido.
    Davis SR
    Climacteric; 2013 Aug; 16 Suppl 1():18-24. PubMed ID: 23647457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone for low libido in postmenopausal women not taking estrogen.
    Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
    N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer in female-to-male transsexuals: two cases with a review of physiology and management.
    Shao T; Grossbard ML; Klein P
    Clin Breast Cancer; 2011 Dec; 11(6):417-9. PubMed ID: 21831723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone therapy for sexual dysfunction in postmenopausal women.
    Hubayter Z; Simon JA
    Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg S
    J Sex Med; 2007 Mar; 4 Suppl 3():227-34. PubMed ID: 17394595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone therapy for postmenopausal women: efficacy and safety.
    Somboonporn W
    Semin Reprod Med; 2006 Apr; 24(2):115-24. PubMed ID: 16633985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone therapy in women: a review.
    Bolour S; Braunstein G
    Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.